Boost Weight Loss Drug Stocks Amid Novo and Eli Lilly Surge
Shares of Novo and Eli Lilly have seen a significant rise following strong indicators for the expansion of the weight loss drug market. This comes at a time when the need for effective solutions to obesity is increasingly urgent in many societies.